With national opioid litigation heating up, Endo and Allergan saw an off-ramp and took it, agreeing to settle with two Ohio counties for a combined $16 million this week. But the state’s attorney general has a message for the drugmakers:
read moreAmgen may be on the verge of acquiring Alexion for $200 per share, a Spanish news site reported Thursday. Analysts say the deal makes sense and would prop up Amgen’s top and bottom lines, which are under pressure from biosimilar
read moreThe decision is based on results from the landmark Phase III CREDENCE study More: EMA accepts license extension submission for Invokana and Vokanamet Source: News
read moreIs Pfizer’s mature drugs’ decline in China an ill omen for other multinational pharmas? AstraZeneca and GlaxoSmithKline are racing their oral anemia drugs to China and Japan. Biomedical leaders voice concerns over “a climate of fear” created by the U.S.
read moreData showed that those who had been given at least two previous courses were 32% more likely to fail to respond to a subsequent course. More: Multiple antibiotic courses linked to pediatric treatment failure Source: News
read moreAntiseptic such as hydrogen peroxide 1% cream is ‘just as effective’ as a topical antibiotic. More: NICE recommends antiseptics over antibiotics for impetigo Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals